QuatRx Pharmaceuticals Company

QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas. We currently have four product candidates in clinical development. Our two lead compounds, Ophena™ and fispemifene, treat hormone deficiencies that result from aging in men and women.